EMROSI (Minocycline Hydrochloride Extended-Release) Capsules

EMROSI, from Journey Medical Corporation, is a dual-release (immediate + extended-release) oral minocycline capsule indicated for the treatment of inflammatory lesions (papules and pustules) of rosacea in adults.

EMROSI delivers minocycline at a sub-antimicrobial, anti-inflammatory dose through a dual-release capsule (an immediate-release portion plus extended-release beads), aiming to reduce rosacea-associated inflammation while limiting antibiotic exposure compared to standard-dose tetracyclines.

• Tetracycline-class drugs can cause photosensitivity — sun protection is advised.
• Not recommended during pregnancy or in young children due to risk of permanent tooth discoloration.
• Rare risk of intracranial hypertension, drug-induced lupus-like syndrome, and hepatotoxicity associated with tetracyclines.
• Common side effects: nausea, headache, diarrhea, photosensitivity, nasopharyngitis.

What documents are required to import EMROSI to India?

EMROSI may be imported in the patient’s name only, by patients or government hospitals. The following documentation is required:

• A valid prescription from a registered dermatologist
• Patient ID proof (issued by the Government of India)

How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription and an import permit, if applicable.

Is EMROSI available in India?

EMROSI is not commercially marketed in India. It can be legally accessed through the Named Patient Program (NPP).

Indian Pharma Network (IPN) can source EMROSI from Journey Medical’s authorized distribution network and facilitate supply to patients, doctors, and hospitals under applicable legal provisions.

For EMROSI cost in India and availability, contact IPN at Phone: +91-9310090915 or email info@indianpharmanetwork.in.

Global Approval Status:

• United States: Approved by the FDA — November 1, 2024.

What is EMROSI used for?

EMROSI treats the inflammatory lesions (papules and pustules) of rosacea in adults.

Who manufactures EMROSI?

EMROSI is manufactured by Journey Medical Corporation.

How is EMROSI different from regular minocycline?

It uses a dual-release (immediate + extended-release) formulation dosed for anti-inflammatory effect, not as a standard antibiotic dose.

How much does EMROSI cost in India?

Cost depends on monthly quantity and sourcing logistics — share your prescription with IPN for a quote.